Monthly Archives: February 2020

How artificial intelligence can control disease outbreaks

2020-02-28T23:03:07-05:00

Watch Ann Marie Sastry's interview on CNBC's “Squawk Alley”. The CEO of AMESITE talks about her company and how artificial intelligence can be used in disease outbreaks and even to track the coronavirus. WATCH NOW

How artificial intelligence can control disease outbreaks2020-02-28T23:03:07-05:00

Laidlaw served as Co-Manager on the $21.75mm EyePoint Pharmaceuticals (EYPT) Follow-On Offering.

2020-02-21T20:31:49-05:00

Laidlaw Capital Markets is pleased to announce today's pricing of a $21,750,000 Follow-On Offering for EyePoint Pharmaceuticals (EYPT). Laidlaw proudly served as Co-Manager alongside Guggenheim, who was Sole Book-Runner on the transaction. See full Press Release on Eyepoint Website

Laidlaw served as Co-Manager on the $21.75mm EyePoint Pharmaceuticals (EYPT) Follow-On Offering.2020-02-21T20:31:49-05:00

Defiance ETFs LLC Rings The Closing Bell®

2020-02-07T14:32:54-05:00

Laidlaw was proud to attend the closing bell ceremony at the NYSE yesterday. Defiance ETFs LLC is the first 5G ETF (NYSE Arca: FIVG) Alex Shtaynberger, Richard Calhoun and Keith Hassan from Laidlaw attended and were on the Podium. Watch as Matthew Bielski, Chief Executive Officer of Defiance ETFs rings The Closing Bell®. Defiance ETFs LLC Read More...

Defiance ETFs LLC Rings The Closing Bell®2020-02-07T14:32:54-05:00

Laidlaw served as Co-Manager on the $90mm Ziopharm Oncology (ZIOP) Follow-On Offering

2020-02-05T19:25:14-05:00

Laidlaw Capital Markets is pleased to announce today’s pricing of a $90,000,000 Follow-On Offering for Ziopharm Oncology (ZIOP). Laidlaw proudly served as Co-Manager alongside Jefferies, who was Sole-Book Runner on the transaction. See full Press Release on Ziopharm Website

Laidlaw served as Co-Manager on the $90mm Ziopharm Oncology (ZIOP) Follow-On Offering2020-02-05T19:25:14-05:00

David Garrity: Laidlaw in the News – Tech Sector 4Q19 Results

2020-02-03T16:17:13-05:00

Tech - Cloud Computing Growth Remains Solid, But Quality Control Issues Threaten Tech Majors: One of the major shifts of interest to investors has been that of enterprise computing to "cloud" platforms. In this regard, there have been three major competitors - AMZN, GOOGL & MSFT. While GOOGL results won't be out until after the close Mon 10/28, the indications from AMZN (AWS 3Q19 revenues $9bn, +34.7% year/year vs. +37% y/y in 2Q19) and MSFT (Commercial Cloud 3Q19 revenues $11.6bn, +36% y/y) indicate that while cloud adoption growth is decelerating from earlier levels, it still remains quite solid. With major growth areas such as cloud computing remaining robust, the near-term prospects for the tech sector remain positive...

David Garrity: Laidlaw in the News – Tech Sector 4Q19 Results2020-02-03T16:17:13-05:00
Go to Top